To include your compound in the COVID-19 Resource Center, submit it here.

EMA grants CTI extension to respond to Day 120 questions for pacritinib

CTI BioPharma Corp. (NASDAQ:CTIC) said EMA's CHMP granted it a three month extension to

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE